(Q55462976)

12 July 2018

title

Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells. (English)

1 reference

12 July 2018

0 references

11

Vivaldo Moura-Neto

1 reference

12 July 2018

Tercia Rodrigues Alves

1

1 reference

12 July 2018

Anna Carolina Carvalho da Fonseca

2

1 reference

12 July 2018

Sara Santana Nunes

3

1 reference

12 July 2018

Aline Oliveira da Silva

4

1 reference

12 July 2018

Luiz Gustavo Feijó Dubois

5

1 reference

12 July 2018

Jane Faria

6

1 reference

12 July 2018

Suzana Assad Kahn

7

1 reference

12 July 2018

Nathan Bessa Viana

8

1 reference

12 July 2018

Jorge Marcondes

9

1 reference

12 July 2018

Chantal Legrand

10

1 reference

12 July 2018

Verônica Morandi

12

1 reference

12 July 2018

language of work or name

English

0 references

publication date

25 June 2011

1 reference

12 July 2018

Experimental Cell Research

published in

1 reference

12 July 2018

volume

317

1 reference

12 July 2018

issue

15

1 reference

12 July 2018

page(s)

2073-2085

1 reference

12 July 2018

Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Requirement of vascular integrin alpha v beta 3 for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Control of adhesion-dependent cell survival by focal adhesion kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Endothelial-mural cell signaling in vascular development and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

The role of tenascin-C in tissue injury and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

The role of the extracellular matrix in angiogenesis in malignant glioma tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Tenascin-C induced signaling in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Tenascin-C matrix assembly in oral squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Immunochemical and biochemical characterization of a glioma-associated extracellular matrix glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Clinical impact and functional aspects of tenascin-C expression during glioma progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Abnormal microcirculation in brain tumours during surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Aberrant vascular architecture in tumors and its importance in drug-based therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Vascular microenvironment in gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

The blood-brain barrier and oncology: new insights into function and modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

T3 affects cerebellar astrocyte proliferation, GFAP and fibronectin organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

STI1 promotes glioma proliferation through MAPK and PI3K pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Proinflammatory cytokines (interleukin-1 beta and tumor necrosis factor-alpha) down regulate synthesis and secretion of thrombospondin by human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

The in vitro interaction of Sporothrix schenckii with human endothelial cells is modulated by cytokines and involves endothelial surface molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Alternagin-C, a disintegrin-like protein, induces vascular endothelial cell growth factor (VEGF) expression and endothelial cell proliferation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Growth promoting signaling by tenascin-C [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Adhesion modulation by antiadhesive molecules of the extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Tenascin interferes with fibronectin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Binding of tenascin-C to soluble fibronectin and matrix fibrils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Localization of a cryptic binding site for tenascin on fibronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Comparative mechanisms of branching morphogenesis in diverse systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Fibronectins in vascular morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Fibronectin requirement in branching morphogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

Spatiotemporal changes of fibronectin, tenascin-C, fibulin-1, and fibulin-2 in the skin during the development of chronic contact dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.006

10.1016/J.YEXCR.2011.06.006

7 January 2021

Identifiers

DOI

1 reference

12 July 2018

PubMed ID

21740900

1 reference

12 July 2018